Export

Filgrastim
Essential medicine status
General description
Filgrastim is a recombinant human granulocyte colony stimulating factor (G-CSF) which stimulates production and differentiation of neutrophils for treatment and prevention of neutropenia.
INN
Filgrastim
Medicine type
Biological agent
EML status history
First added in 2015 (TRS 994) for Acquired neutropenias
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Immunomodulators
  • Parenteral > General injections > SC: 120 µg per 0.2 mL in prefilled syringe; 300 µg per 0.5 mL in prefilled syringe; 480 µg per 0.8 mL in prefilled syringe; 300 µg per mL in 1 mL vial; 480 µg per 1.6 mL in 1.6 mL vial